Clinical Potential of Extracellular Vesicles in Type 2 Diabetes

Type 2 diabetes (T2D) is a major public health disease which is increased in incidence and prevalence throughout the whole world. Insulin resistance (IR) in peripheral tissues and insufficient pancreatic β-cell mass and function have been recognized as primary mechanisms in the pathogenesis of T2D,...

Full description

Bibliographic Details
Main Authors: Jie Liu, Xin Sun, Fu-Liang Zhang, Hang Jin, Xiu-Li Yan, Shuo Huang, Zhen-Ni Guo, Yi Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2020.596811/full
id doaj-f72509879d294751afbd1893f68c2e65
record_format Article
spelling doaj-f72509879d294751afbd1893f68c2e652021-01-21T09:37:04ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-01-011110.3389/fendo.2020.596811596811Clinical Potential of Extracellular Vesicles in Type 2 DiabetesJie Liu0Jie Liu1Jie Liu2Xin Sun3Xin Sun4Fu-Liang Zhang5Fu-Liang Zhang6Hang Jin7Hang Jin8Xiu-Li Yan9Shuo Huang10Shuo Huang11Shuo Huang12Zhen-Ni Guo13Zhen-Ni Guo14Zhen-Ni Guo15Yi Yang16Yi Yang17Yi Yang18Stroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, ChinaChina National Comprehensive Stroke Center, Changchun, ChinaJilin Provincial Key Laboratory of Cerebrovascular Disease, Changchun, ChinaStroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, ChinaChina National Comprehensive Stroke Center, Changchun, ChinaStroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, ChinaChina National Comprehensive Stroke Center, Changchun, ChinaStroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, ChinaChina National Comprehensive Stroke Center, Changchun, ChinaStroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, ChinaStroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, ChinaChina National Comprehensive Stroke Center, Changchun, ChinaJilin Provincial Key Laboratory of Cerebrovascular Disease, Changchun, ChinaStroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, ChinaChina National Comprehensive Stroke Center, Changchun, ChinaJilin Provincial Key Laboratory of Cerebrovascular Disease, Changchun, ChinaStroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, ChinaChina National Comprehensive Stroke Center, Changchun, ChinaJilin Provincial Key Laboratory of Cerebrovascular Disease, Changchun, ChinaType 2 diabetes (T2D) is a major public health disease which is increased in incidence and prevalence throughout the whole world. Insulin resistance (IR) in peripheral tissues and insufficient pancreatic β-cell mass and function have been recognized as primary mechanisms in the pathogenesis of T2D, while recently, systemic chronic inflammation resulting from obesity and a sedentary lifestyle has also gained considerable attention in T2D progression. Nowadays, accumulating evidence has revealed extracellular vesicles (EVs) as critical mediators promoting the pathogenesis of T2D. They can also be used in the diagnosis and treatment of T2D and its complications. In this review, we briefly introduce the basic concepts of EVs and their potential roles in the pathogenesis of T2D. Then, we discuss their diagnostic and therapeutic potentials in T2D and its complications, hoping to open new prospects for the management of T2D.https://www.frontiersin.org/articles/10.3389/fendo.2020.596811/fulltype 2 diabetesextracellular vesiclesmechanismdiagnosistreatment
collection DOAJ
language English
format Article
sources DOAJ
author Jie Liu
Jie Liu
Jie Liu
Xin Sun
Xin Sun
Fu-Liang Zhang
Fu-Liang Zhang
Hang Jin
Hang Jin
Xiu-Li Yan
Shuo Huang
Shuo Huang
Shuo Huang
Zhen-Ni Guo
Zhen-Ni Guo
Zhen-Ni Guo
Yi Yang
Yi Yang
Yi Yang
spellingShingle Jie Liu
Jie Liu
Jie Liu
Xin Sun
Xin Sun
Fu-Liang Zhang
Fu-Liang Zhang
Hang Jin
Hang Jin
Xiu-Li Yan
Shuo Huang
Shuo Huang
Shuo Huang
Zhen-Ni Guo
Zhen-Ni Guo
Zhen-Ni Guo
Yi Yang
Yi Yang
Yi Yang
Clinical Potential of Extracellular Vesicles in Type 2 Diabetes
Frontiers in Endocrinology
type 2 diabetes
extracellular vesicles
mechanism
diagnosis
treatment
author_facet Jie Liu
Jie Liu
Jie Liu
Xin Sun
Xin Sun
Fu-Liang Zhang
Fu-Liang Zhang
Hang Jin
Hang Jin
Xiu-Li Yan
Shuo Huang
Shuo Huang
Shuo Huang
Zhen-Ni Guo
Zhen-Ni Guo
Zhen-Ni Guo
Yi Yang
Yi Yang
Yi Yang
author_sort Jie Liu
title Clinical Potential of Extracellular Vesicles in Type 2 Diabetes
title_short Clinical Potential of Extracellular Vesicles in Type 2 Diabetes
title_full Clinical Potential of Extracellular Vesicles in Type 2 Diabetes
title_fullStr Clinical Potential of Extracellular Vesicles in Type 2 Diabetes
title_full_unstemmed Clinical Potential of Extracellular Vesicles in Type 2 Diabetes
title_sort clinical potential of extracellular vesicles in type 2 diabetes
publisher Frontiers Media S.A.
series Frontiers in Endocrinology
issn 1664-2392
publishDate 2021-01-01
description Type 2 diabetes (T2D) is a major public health disease which is increased in incidence and prevalence throughout the whole world. Insulin resistance (IR) in peripheral tissues and insufficient pancreatic β-cell mass and function have been recognized as primary mechanisms in the pathogenesis of T2D, while recently, systemic chronic inflammation resulting from obesity and a sedentary lifestyle has also gained considerable attention in T2D progression. Nowadays, accumulating evidence has revealed extracellular vesicles (EVs) as critical mediators promoting the pathogenesis of T2D. They can also be used in the diagnosis and treatment of T2D and its complications. In this review, we briefly introduce the basic concepts of EVs and their potential roles in the pathogenesis of T2D. Then, we discuss their diagnostic and therapeutic potentials in T2D and its complications, hoping to open new prospects for the management of T2D.
topic type 2 diabetes
extracellular vesicles
mechanism
diagnosis
treatment
url https://www.frontiersin.org/articles/10.3389/fendo.2020.596811/full
work_keys_str_mv AT jieliu clinicalpotentialofextracellularvesiclesintype2diabetes
AT jieliu clinicalpotentialofextracellularvesiclesintype2diabetes
AT jieliu clinicalpotentialofextracellularvesiclesintype2diabetes
AT xinsun clinicalpotentialofextracellularvesiclesintype2diabetes
AT xinsun clinicalpotentialofextracellularvesiclesintype2diabetes
AT fuliangzhang clinicalpotentialofextracellularvesiclesintype2diabetes
AT fuliangzhang clinicalpotentialofextracellularvesiclesintype2diabetes
AT hangjin clinicalpotentialofextracellularvesiclesintype2diabetes
AT hangjin clinicalpotentialofextracellularvesiclesintype2diabetes
AT xiuliyan clinicalpotentialofextracellularvesiclesintype2diabetes
AT shuohuang clinicalpotentialofextracellularvesiclesintype2diabetes
AT shuohuang clinicalpotentialofextracellularvesiclesintype2diabetes
AT shuohuang clinicalpotentialofextracellularvesiclesintype2diabetes
AT zhenniguo clinicalpotentialofextracellularvesiclesintype2diabetes
AT zhenniguo clinicalpotentialofextracellularvesiclesintype2diabetes
AT zhenniguo clinicalpotentialofextracellularvesiclesintype2diabetes
AT yiyang clinicalpotentialofextracellularvesiclesintype2diabetes
AT yiyang clinicalpotentialofextracellularvesiclesintype2diabetes
AT yiyang clinicalpotentialofextracellularvesiclesintype2diabetes
_version_ 1724330088010350592